Global deep brain stimulation systems market is projected to register a CAGR of 8.5% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation
By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), Application (Obsessive Compulsive Disorder, Parkinson's Disease, Essential Tremor, Epilepsy, Dystonia), Type (Rechargeable, Non-Rechargeable), End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Switzerland, Russia, Netherland, Belgium, Turkey, rest of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa, Rest of Middle East and Africa)

Some of the major factors contributing to the growth of the market are:
- Increasing health care expenditure.
- Technology advancement in surgery procedure.

Market Players
The key market players for global deep brain stimulation systems market are listed below:

- Medtronic
- Boston Scientific Corporation
- Abbott
- Aleva Neurotherapeutics SA
- Neuropace, Inc.
- Beijing Pins Medical Co., Ltd.
- Sceneray Corporation, Limited
- Fisher Wallace